Panacea Biotec Ltd

NSE: PANACEABIO · BSE: 531349 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹357.40
Market cap: ₹2,189 Cr
Revenue (annual): ₹639.8 Cr
Net profit (annual): ₹-5.37 Cr
P/E (TTM): -307.5×Sector 47.4×
Promoter holding: 72.48%+0.00% QoQ
FII holding: 2.31%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 4 Promoter Buying (Off-Market) 2 Other Announcement 2 New Order Win 1 Financial Results 1 Capital Structure Change 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

5 Aug 2026 09:39 IST BSE

New Order Win

Panacea Biotec Bags ₹78.24 Cr Order

Panacea Biotec Ltd secured a Letter of Award from UNICEF worth approximately Rs.78.24 Crore ($8.205 million). The contract involves supplying bivalent Oral Polio Vaccine during 2028.

Value: ₹78.24 Cr
Execution: Calendar Year 2028

Read the filing ↗